Non-covalent inhibitors targeting SARS-CoV-2 3CLpro: structural insights and developmental landscape.
- DOI
- 10.1007/s12272-026-01645-6
- Published
- 2026 Nov 3
- Container
- Archives of pharmacal research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12272-026-01645-6,
title = {Non-covalent inhibitors targeting SARS-CoV-2 3CLpro: structural insights and developmental landscape.},
author = {Rajaka L and Goins CM and Kim DH and Lee J and Kwon K and Baek S and Stauffer SR and Han SH},
year = {2026},
journal = {Archives of pharmacal research},
doi = {10.1007/s12272-026-01645-6},
url = {https://doi.org/10.1007/s12272-026-01645-6}
}RIS
TY - JOUR TI - Non-covalent inhibitors targeting SARS-CoV-2 3CLpro: structural insights and developmental landscape. AU - Rajaka L AU - Goins CM AU - Kim DH AU - Lee J AU - Kwon K AU - Baek S AU - Stauffer SR AU - Han SH PY - 2026 JO - Archives of pharmacal research DO - 10.1007/s12272-026-01645-6 UR - https://doi.org/10.1007/s12272-026-01645-6 ER -
APA
L, R., CM, G., DH, K., J, L., K, K., S, B., SR, S., & SH, H. (2026). Non-covalent inhibitors targeting SARS-CoV-2 3CLpro: structural insights and developmental landscape.. Archives of pharmacal research. https://doi.org/10.1007/s12272-026-01645-6
Source records
- pubmed · retrieved 2026-11-10T12:24:13.015Z